EVENTS:   The Roaring 2020s or a Rerun of the 1970s? - Edward Yardeni/Yardeni Research - 24 Mar 26   Best Equity Short Ideas Conference Call 13 - Thomas Chanos/Badger Consultants & Dr. Aaron Fletcher/Bios Research & Jonathan Telgener/Channel Dynamics & Ed Steele/Iron Blue Financials & John Zolidis/Quo Vadis Capital & Mark Hiley/The Analyst - 26 Mar 26     ROADSHOWS: Chinese Equity Ideas & Channel Checks Across 50 sub-sectors - Don Ma /Horizon Insights   •   London   23 - 27 Mar 26       Long Short European Equity Research - Harry Grist /The Analyst   •   New York   26 Mar 26       Fundamental US Healthcare Short Ideas - Dr Elliot Favus /Favus Institutional Research   •   London   27 - 27 Mar 26      
Filters

Fortnightly Publication Highlighting Latest Insights From IRF Providers

Company Research

Azelis (AZE BB) Belgium

Materials

Revelare Partners

Revelare, who hosts ~40 idea events p.a. where 300+ investment ideas are sourced from institutional investment clients, recently spoke with an investor who is long AZE, the second largest pure play specialty chemical and food ingredient distributor globally after IMCD. The investor is bullish because he sees AZE exiting 2024 with positive total organic growth for the first time in seven quarters, leading to revenue / EBITA acceleration in 2025 and associated multiple expansion. He believes the stock can appreciate to a ~€30 stock price at the end of 2025 (55% upside). He also considers AZE to be a very strategic asset that may be acquired by private equity or Brenntag in the medium / long-term.

Edition: 195

- 20 September, 2024